pentobarbital will reduce the extent or outcome of exemestane by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. For clients receiving exemestane with a powerful CYP3A4 inducer the proposed dose of exemestane is 50 mg each day following a meal.pentobarbital will lower the extent or result of repaglinide by impacting hepa… Read More